1. Home
  2. DETX vs DARE Comparison

DETX vs DARE Comparison

Compare DETX & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Defense Holdings Ltd. Common Shares

DETX

Liberty Defense Holdings Ltd. Common Shares

N/A

Current Price

$2.16

Market Cap

14.8M

ML Signal

N/A

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$0.72

Market Cap

13.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DETX
DARE
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
13.9M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
DETX
DARE
Price
$2.16
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
19.5K
768.6K
Earning Date
N/A
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,807,885.00
Revenue This Year
N/A
$2,115.12
Revenue Next Year
N/A
$122.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.69
52 Week High
$4.25
$3.78

Technical Indicators

Market Signals
Indicator
DETX
DARE
Relative Strength Index (RSI) 30.31 27.87
Support Level N/A N/A
Resistance Level $4.13 $2.19
Average True Range (ATR) 0.40 0.07
MACD -0.07 0.01
Stochastic Oscillator 4.93 20.04

Price Performance

Historical Comparison
DETX
DARE

About DETX Liberty Defense Holdings Ltd. Common Shares

Liberty Defense Holdings Ltd is engaged in the development and commercialization of security detection technologies such as airports, stadiums, schools, and more. The company's Hexwave product utilizes millimeter wave technology and Advanced 3D imaging to detect concealed threats. In addition to HEXWAVE, the company has licensed High-Definition Advanced Imaging Technology (HD-AIT) for body and shoe scanning. The Company operates through three distinct segments: Corporate, HEXWAVE, and Contract. The company generates the majority of its revenue from the Contract segment. Geographically, the company generates the majority of its revenue from the United States.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: